Skip to content

Asset turnover at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.5×0.0×
Glaukos logo
GlaukosGKOS
0.6×+0.2×
AbbVie logo
AbbVieABBV
0.5×+0.1×
Bausch + Lomb logo
Bausch + LombBLCO
0.4×0.0×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
+0.4×
Boston Scientific logo
Boston ScientificBSX
0.5×0.0×

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Calculated from Sight Sciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s asset turnover?
Sight Sciences, Inc. (SGHT) reported asset turnover of 0.7× in Q1 2026.
How has Sight Sciences, Inc.'s asset turnover changed year-over-year?
Sight Sciences, Inc.'s asset turnover increased by 21.4% year-over-year, from 0.5× to 0.7×.
What is the long-term trend for Sight Sciences, Inc.'s asset turnover?
Over 4 years (2021 to 2025), Sight Sciences, Inc.'s asset turnover has grown at a 21.2% compound annual growth rate (CAGR), from 0.3× to 0.6×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.